Synthesis of α,α-disubstituted 4-phosphonophenylalanine analogues as conformationally-constrained phosphotyrosyl mimetics

Tetrahedron

Volumn 60, Issue 13, 2004, Pages 2971-2977

  Oishi, Shinya ^a   Kang, Sang Uk ^a   Liu, Hongpeng ^b   Zhang, Manchao ^b   Yang, Dajun ^b   Deschamps, Jeffrey R ^c   Burke Jr , Terrence R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NAVAL RESEARCH LABORATORY   (United States)

Author keywords

Conformational constraint; Enantioselective; Phosphotyrosyl mimetic

Indexed keywords

ALDEHYDE DERIVATIVE; AMINO ACID; CARBOXYLIC ACID DERIVATIVE; DIETHYLPHOSPHITE; N TERT BUTYLOXYCARBONYL 2 AMINO 6 (DIETHYLPHOSPHONO)TETRALIN 2 CARBOXYLIC ACID; N TERT BUTYLOXYCARBONYL 4 (DIETHYLPHOSPHONO)(ALPHA METHYL)PHENYLALANINE; PALLADIUM; PHENYLALANINE DERIVATIVE; PHOSPHITE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CATALYST; CHIRALITY; CONFORMATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNTHESIS;

EID: 1542268916     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2004.02.005     Document Type: Article

References (28)

1. Mutter M. Angew. Chem. Int. Ed. Engl. 24:1985;639-653.
2. Babine R.E., Bender S.L. Chem. Rev. 97:1997;1359-1472.
3. Ripka A.S., Rich D.H. Curr. Opin. Chem. Biol. 2:1998;441-452.
4. Hruby V.J., Balse P.M. Curr. Med. Chem. 7:2000;945-970.
5. Bursavich M.G., Rich D.H. J. Med. Chem. 45:2002;541-558.
6. Freidinger R.M. J. Med. Chem. 46:2003;5553-5566.
7. Gibson S.E., Guillo N., Tozer M.J. Tetrahedron. 55:1999;585-615.
8. Prasad B.V.V., Balaram P. CRC Crit. Rev. Biochem. 14:1984;307-348.
9. Rastogi S.N., Bindra J.S., Anand N. Ind. J. Chem. 9:1971;1175-1182.
10. Obrecht D., Altorfer M., Bohdal U., Daly J., Huber W., Labhardt A., Lehmann C., Muller K., Ruffieux R., Schonholzer P., Spiegler C., Zumbrunn C. Biopolymers. 42:1997;575-626.
11. Tsatsanis C., Spandidos D.A. Int. J. Mol. Med. 5:2000;583-590.
12. Renhowe P.A. Ann. Rep. Med. Chem. 36:2001;109-118.
13. Kzardenings A.K., Gordeev M.F., Patel D.V. Tetrahedron Lett. 37:1996;3635-3638.
14. Liu W.Q., Vidal M., Gresh N., Rogues B.P., Garbay C. J. Med. Chem. 42:1999;3737-3741.
15. Petrakis K.S., Nagabhushan T.L. J. Am. Chem. Soc. 109:1987;2831-2833.
16. Bayle-Lacoste M., Moulines J., Collignon N., Boumekouez A., De Tinguy-Moreaud E., Neuzil E. Tetrahedron. 46:1990;7793-7802.
17. Garbay, C.; Liu, W.-Q.; Vidal, M.; Roques, B. P. Preparation of pseudopeptides having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same. US Pat. Appl. Publ. No. US 2002/0055463 A1 (May 9, 2002) for US Appl. No. 09/977,349, filed October 16, 2001. Priority Fr 98/16459 (December 24, 1998).
18. Stankovic C.J., Surendran N., Lunney E.A., Plummer M.S., Para K.S., Shahripour A., Fergus J.H., Marks J.S., Herrera R., Hubbell S.E., Humblet C., Saltiel A.R., Stewart B.H., Sawyer T.K. Bioorg. Med. Chem. Lett. 7:1997;1909-1914.
19. Liu W.Q., Carreaux F., Meudal H., Roques B.P., GarbayJaureguiberry C. Tetrahedron. 52:1996;4411-4422.
20. Liu D.-G., Wang X.-Z., Gao Y., Li B., Yang D., Burke T.R. Jr. Tetrahedron. 58:2002;10423-10428.
21. Williams R.M., Im M.N. J. Am. Chem. Soc. 113:1991;9276-9286.
22. Compound 7 was diastereomerically pure to H NMR.
23. Ishizumi K., Ohashi N., Tanno N. J. Org. Chem. 52:1987;4477-4485.
24. Obrecht D., Spiegler C., Schoenholzer P., Mueller K., Heimgartner H., Stierli F. Helv. Chim. Acta. 75:1992;1666-1696.
25. Yao Z.J., King C.R., Cao T., Kelley J., Milne G.W.A., Voigt J.H., Burke T.R. J. Med. Chem. 42:1999;25-35.
26. Carpino L.A., El-Faham A. J. Am. Chem. Soc. 117:1995;5401-5402.
27. Gao Y., Luo J., Yao Z.-J., Guo R., Zou H., Kelley J., Voigt J.H., Yang D., Burke T.R. Jr. J. Med. Chem. 43:2000;911-920.
28. Davidson J.P., Lubman O., Rose T., Waksman G., Martin S.F. J. Am. Chem. Soc. 124:2002;205-215.